Literature DB >> 10997435

van der Knaap syndrome: MR imaging findings including FLAIR, diffusion imaging, and proton MR spectroscopy.

R N Sener1.   

Abstract

A patient is reported with diffuse leukoencephalopathy associated with cystic degeneration of the white matter of the brain (van der Knaap syndrome). The changes were studied by fluid attenuated inversion recovery (FLAIR), and diffusion-weighted MR imaging. The FLAIR sequence revealed suppressed signal of the cysts, and widespread high-signal white matter changes associated with thinned cortices. On diffusion-weighted MR imaging, apparent diffusion coefficient (ADC) values ranged from 3.0 x 10(-3) to 2.7 x 10(-3) mm2/s in the temporal cysts, similar to that of CSF. The ADC values within the parenchyma ranged between 2 x 10(-3) and 2.1 x 10(-3) mm2/s, a value falling between normal parenchyma and cerebrospinal fluid, compared with a control group of three healthy subjects. The changes were also evaluated by proton MR spectroscopy, and were compared with a control group of 12 cases. Magnetic resonance spectroscopy revealed apparently increased NAA/Cr ratios in most parts of the brain. The NAA/Cho ratios were either high or low, and the Cho/Cr ratios were increased or normal in different regions.

Entities:  

Mesh:

Year:  2000        PMID: 10997435     DOI: 10.1007/s003300000324

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  The dentate nucleus in children: normal development and patterns of disease.

Authors:  Aoife McErlean; Khaled Abdalla; Veronica Donoghue; Stephanie Ryan
Journal:  Pediatr Radiol       Date:  2010-01-28

2.  Demonstration of glycine peaks at 3.50 ppm in a patient with van der Knaap syndrome.

Authors:  R N Sener
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 3.  Diffusion-weighted MR imaging in leukodystrophies.

Authors:  Zoltan Patay
Journal:  Eur Radiol       Date:  2005-07-15       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.